The immediate pressor response to saralasin in man: a test of angiotensin II receptor vacancy
- PMID: 214254
- DOI: 10.1161/01.res.44.1.38
The immediate pressor response to saralasin in man: a test of angiotensin II receptor vacancy
Abstract
Saralasin, 10 microgram/kg per min, caused an immediate rise in blood pressure in 52 of 57 (91.2%) hypertensive patients. The increase in diastolic pressure averaged 18.8 +/- 1.83 mm Hg (mean +/- SE) in normal renin patients on a normal salt intake. This immediate pressor response was absent in only five high renin patients and, conversely, was very large in three low renin patients. Direct arterial recordings are necessary to define the response accurately; it begins in 60--90 seconds, peaks in amplitude at 2.05 +/- 0.38 minutes, and subsides over the next 5 minutes in normal renin and high renin patients. The blood pressure elevation is inversely related to background plasma renin activity (r = -0.66, P less than 0.001), and also is directly, but weakly, related to 24-hour urinary sodium excretion (r = + 0.29). Therefore, the amplitude of the elevation is predictably diminished by the rise in plasma renin consequent to prior sodium restriction, and also by preliminary receptor exposure to low dose nonpressor infusions of saralasin itself (0.01-0.1 microgram/kg per min). Phentolamine had no effect on the response in two patients. We propose that the immediate pressor response to saralasin is related directly to the preexisting degree of vacancy of angiotensin II vascular receptors and that the initial agonistic action of the drug may prove useful in defining the angiotensin II receptor status in hypertensive diseases.
Similar articles
-
The immediate pressor response to saralasin: a measure of the degree of angiotensin II vascular receptor vacancy.Trans Assoc Am Physicians. 1977;90:300-12. Trans Assoc Am Physicians. 1977. PMID: 205983
-
Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.Circ Res. 1977 Mar;40(3):243-50. doi: 10.1161/01.res.40.3.243. Circ Res. 1977. PMID: 837471
-
Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.Am J Med. 1976 May 31;60(6):825-36. doi: 10.1016/0002-9343(76)90903-7. Am J Med. 1976. PMID: 1020762
-
Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.Kidney Int Suppl. 1979 Mar;(9):S29-35. Kidney Int Suppl. 1979. PMID: 384070 Review. No abstract available.
-
Adrenergic facilitation by angiotensin: does it serve a physiological function?Clin Sci (Lond). 1981 Apr;60(4):343-8. doi: 10.1042/cs0600343. Clin Sci (Lond). 1981. PMID: 6265136 Review. No abstract available.
Cited by
-
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.Drugs. 1984 Aug;28(2):144-69. doi: 10.2165/00003495-198428020-00004. Drugs. 1984. PMID: 6205842 Review.
-
Effects of two angiotensin II analogues on blood pressure, plasma aldosterone concentration, plasma renin activity and creatinine clearance in normal subjects on different sodium intakes.Eur J Clin Pharmacol. 1980 Oct;18(4):295-9. doi: 10.1007/BF00561385. Eur J Clin Pharmacol. 1980. PMID: 7002566
-
A comparison of the ability of two angiotensin II receptor blocking drugs, 1-Sar; 8-Ala angiotensin II and 1-Sar, 8-Ile angiotensin II, to modify the regulation of glomerular filtration rate in the cat.Br J Pharmacol. 1980;71(2):499-506. doi: 10.1111/j.1476-5381.1980.tb10963.x. Br J Pharmacol. 1980. PMID: 7470759 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources